Results 51 to 60 of about 843,055 (126)

Musculoskeletal disorders and coronary artery disease —promising molecular markers: literature review [PDF]

КардиоСоматика
Currently, increasing evidence shows that people with cardiovascular diseases, including coronary heart disease, have a higher risk of developing pathologies such as sarcopenia, osteopenia, osteosarcopenia, sarcopenic, and osteosarcopenic obesity, which ...
Viktoria N. Karetnikova, Anastasiya G. Neeshpapa, Evgenia I. Carpova, Olga L. Barbarash   +3 more
doaj   +1 more source

Potential of bioimpedance analysis for diagnostics of osteosarcopenic obesity components

Siberian Journal of Clinical and Experimental Medicine
Rationale. Physiological aging has all the factors that contribute to the development of obesity, sarcopenia and osteoporosis through increased fat mass, decreased muscle mass and strength, and decreased bone mass.
D. Tsygankova, K. Krivoshapova, E. Bazdyrev, A. Kareeva, G. Artamonova, O. Barbarash   +5 more
semanticscholar   +1 more source

Osteosarcopenic Obesity’s Role in Older Adults’ Falls and Vertebral Fractures

European Journal of Geriatrics and Gerontology
Objective: The co-occurrence of osteoporosis, sarcopenia, and obesity is known as osteosarcopenic obesity (OSO). This study examined the frequency of OSO in older adult outpatients and its connection to falls and spinal fractures.
Burcu Eren Cengiz, S. Akın, Yavuz Sultan Selim Akgül, Nurhayat Tuğra Özer, Derya Koçaslan, Neziha Ozlem Deveci   +5 more
semanticscholar   +1 more source

From Pixels to Prediction: Reviewing the Role of Artificial Intelligence in Body Composition Analysis

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 3, June 2026.
ABSTRACT Evaluation of body composition (BC) is a set of biomarkers, including fat, muscle and bone, that allows the quantification of an individual's composition at different levels of complexity (whole body, tissues, macroscopic and microscopic). Recently, BC has gained medical interest due to its impact on health outcomes in both oncologic and non ...
Marta Zerunian, Benedetta Masci, Stefano Nardacci, Federico Perconti, Lapo Nardoni, Vincenzo Solimene, Michela Polici, Francesco Pucciarelli, Tiziano Polidori, Domenico De Santis, Andrea Laghi, Damiano Caruso   +11 more
wiley   +1 more source

Why Osteosarcopenia Matters: Clinical and Investigative Implications

European Journal of Clinical Investigation, Volume 56, Issue 5, May 2026.
Osteosarcopenia: Non‐pharmacological and pharmacological treatment strategies. ABSTRACT Background Osteosarcopenia, the combination of osteoporosis and sarcopenia, is a geriatric syndrome linked to functional decline, falls, and fragility fractures. The interaction among bone, muscle, and their shared pathophysiology is driven by mechanical, metabolic,
Erik Luiz Bonamigo, Marcella Nora Maia, Renata Pinheiro Cavallaro de Oliveira, Régis Gemerasca Mestriner, Ivan Aprahamian, Gustavo Duque   +5 more
wiley   +1 more source

Aging‐Driven Inter‐Organ Crosstalk in Postmenopausal Osteoporosis: From Immunometabolic Drift to Multisystem Frailty

The FASEB Journal, Volume 40, Issue 4, 28 February 2026.
Postmenopausal osteoporosis (PMOP) is increasingly recognized as an aging‐associated, multisystem state of fragility, in which estrogen deficiency exacerbates immune and metabolic drift across the bone marrow, skeletal muscle, adipose tissue, gut, vascular system, and neural circuits.
Xianlin Rao, Xiaoyu Cai
wiley   +1 more source

Imaging methods for assessing fat depot status in osteosarcopenic obesity

CARDIOVASCULAR THERAPY AND PREVENTION
Aim . To analyze the incidence of osteosarcopenic obesity (OSO) using various fat depot indices in patients with multivessel coronary artery disease. Material and methods .
D. Tsygankova, K. Krivoshapova, E. Bazdyrev, D. Tsygankov, A. Kareeva, M. A. Smetankina, T. S. Yelenskaya, V. Karetnikova, A. Neeshpapa, O. Barbarash   +9 more
semanticscholar   +1 more source

Prediabetes Associates With Musculoskeletal Alterations Independent of Total Body Adiposity

Journal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Excess adiposity is a major risk factor for insulin resistance, prediabetes, and Type 2 diabetes and increases the risk for sarcopenia and osteosarcopenia later in life. It has been proposed that altered metabolic function and musculoskeletal status in people with obesity are directly linked, presumably because they share common ...
Alan Fappi, Clifton J. Holmes, Chao Cao, Vasavi Shabrish, Aman P. Aher, Karen Shen, Paul K. Commean, Dwight A. Towler, Dominic N. Reeds, Gretchen A. Meyer, Bettina Mittendorfer   +10 more
wiley   +1 more source

Influence of Resistance Training Variables to Improve Muscle Mass Outcomes in Sarcopenia: A Systematic Review With Meta‐Regressions

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 6, December 2025.
ABSTRACT Background Resistance training (RT) is the first‐line treatment to improve sarcopenia features. However, increasing muscle mass with RT remains challenging and displays inconsistent results. Manipulating training variables may present a novel approach to improve muscle mass gain in sarcopenic individuals. The present study aimed to measure the
Leo Delaire, Aymeric Courtay‐Breuil, Joannès Humblot, Hubert Vidal, Marc Bonnefoy, Emmanuelle Meugnier   +5 more
wiley   +1 more source

Sarcopenic obesity in males: from etiopathogenesis to therapeutic strategies in treatment

Клинический разбор в общей медицине
Sarcopenic obesity (SO) is a distinct phenotype of obesity characterized by the coexistence of excessive fat accumulation and reduced skeletal muscle mass and function.
Fatima K. Dzgoeva, Viktoria V. Demidova
doaj   +1 more source